Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: long-term outcomes of a randomised trial.

Reijntjes, B.; Suijlichem, M. van; Woolderink, J.M.; Bongers, M.Y.; Reesink-Peters, N.; Paulsen, L.; ... ; Mourits, M.J.E. (2021)

Article / Letter to editor

Background 

Laparoscopic hysterectomy is accepted worldwide as the standard treatment option for early-stage endometrial cancer. However, there are limited data on long-term survival, particularly when no lymphadenectomy is performed. We compared the survival outcomes of total laparoscopic hysterectomy (TLH) and total abdominal hysterectomy (TAH), both without lymphadenectomy, for early-stage endometrial cancer up to 5 years postoperatively.

Methods

Follow-up of a multi-centre, randomised controlled trial comparing TLH and TAH, without routine lymphadenectomy, for women with stage I endometrial cancer. Enrolment was between 2007 and 2009 by 2:1 randomisation to TLH or TAH. Outcomes were disease-free survival (DFS), overall survival (OS), disease-specific survival (DSS), and primary site of recurrence. Multivariable Cox regression analyses were adjusted for age, stage, grade, and radiotherapy with adjusted hazard ratios (aHR) and 95% confidence intervals (95%CI) reported. To test for significance, non-inferiority margins were defined.

Results

In total, 279 women underwent a surgical procedure, of whom 263 (94%) had follow-up data. For the TLH (n = 175) and TAH (n = 88) groups, DFS (90.3% vs 84.1%; aHR[recurrence], 0.69; 95%CI, 0.31–1.52), OS (89.2% vs 82.8%; aHR[death], 0.60; 95%CI, 0.30–1.19), and DSS (95.0% vs 89.8%; aHR[death], 0.62; 95%CI, 0.23–1.70) were reported at 5 years. At a 10% significance level, and with a non-inferiority margin of 0.20, the null hypothesis of inferiority was rejected for all three outcomes. There were no port-site or wound metastases, and local recurrence rates were comparable.

Conclusion

Disease recurrence and 5-year survival rates were comparable between the TLH and TAH groups and comparable to studies with lymphadenectomy, supporting the widespread use of TLH without lymphadenectomy as the primary treatment for early-stage, low-grade endometrial cancer.

• All authors: Reijntjes, B.; Suijlichem, M. van; Woolderink, J.M.; Bongers, M.Y.; Reesink-Peters, N.; Paulsen, L.; Hurk, P.J. van der; Kraayenbrink, A.A.; Apperloo, M.J.A.; Slangen, B.; Schukken, T.; Tummers, F.H.M.P.; Kesteren, P.J.M. van; Huirne, J.A.F.; Boskamp, D.; Lunter, G.; Bock, G.H. de; Mourits, M.J.E.
• Date: 2021-12-23
• Journal: Gynecologic Oncology
• Volume: 164
• Issue: 2
• Pages: 39 - 265
• DOI: doi:10.1016/j.ygyno.2021.12.019